General Information of the Compound
Compound ID
CP0528667
Compound Name
6-(3-chlorophenyl)-4,4-diethyl-1H-3,1-benzoxazine-2-thione
    Show/Hide
Structure
Formula
C18H18ClNOS
Molecular Weight
331.868
Canonical SMILES
CCC1(CC)OC(=S)Nc2ccc(cc12)-c1cccc(Cl)c1
    Show/Hide
InChI
InChI=1S/C18H18ClNOS/c1-3-18(4-2)15-11-13(12-6-5-7-14(19)10-12)8-9-16(15)20-17(22)21-18/h5-11H,3-4H2,1-2H3,(H,20,22)
    Show/Hide
InChIKey
HWFFFZIEYMMDDC-UHFFFAOYSA-N
Physicochemical Property
logP
5.7493
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
21.26
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10471922
SID: 15495323
ChEMBL ID
CHEMBL277422
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
EC50 = 7.2 nM
   TI
   LI
   LO
   TS